MetaCap

Akanda (AKAN) vs Biote (BTMD)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.

Summary

Biote is the larger company by market cap ($38.3 million vs $4.7 million), about 8.2 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Head-to-head

AKAN versus BTMD key metrics
MetricAKANBTMD
Share price$1.78$1.13
Market cap$4.70M$38.31M
1-day change-7.77%+1.80%
YTD return—-57.31%
1-year return—-60.92%
5-year return—-88.64%
P/E ratio (TTM)—8.07
Forward P/E—2.51
EPS (TTM)$-14,935.32$0.14
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
52-week high$78.90$3.26
52-week low$1.78$1.07
Distance from 52-week high-97.74%-65.34%
Average volume1.35M230.27K
Shares outstanding2.39M28.68M
SectorHealth CareHealth Care
Industry Medicinal Chemicals and Botanical Products Medicinal Chemicals and Botanical Products

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • Biote is about 8.2 times larger than Akanda by market value ($38.31M vs $4.70M).

AKAN vs BTMD FAQ

Which is bigger, Akanda or Biote?

Biote (BTMD) is larger, with a market capitalization of $38.31M compared with $4.70M for Akanda (AKAN).

Are Akanda and Biote in the same industry?

Yes. Both are classified in the Medicinal Chemicals and Botanical Products industry within the Health Care sector.

More comparisons